Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes.
Some of the situations where measurement of drug dosage concentration is useful include, non-response at therapeutic dose, suboptimal tolerability, pharmacokinetic drug-drug interaction and drug adherence. TDM is regarded as a module of personalized medicine that interacts with various other disciplines such as pharmacogenomics and pharmacokinetics. Most commonly monitored drugs are digoxin, valproate and carbamazepine.
The global therapeutic drug monitoring market showed significant growth over the last few years and is projected to grow at a robust CAGR during the forecast period.
Therapeutic Drug MonitoringMarket: Drivers and Restraints
Therapeutic drug monitoring is driven by various key factors which include, ageing population with better health care services, increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring markets, rise in drug profiling.
Browse Full Report@ http://www.futuremarketinsights.com/reports/therapeutic-drug-monitoring-market
Ongoing problems with reimbursement, retrenchment in the hospital fields and a weak global economy. Fluctuating exchange rates further weakens the global market.
Therapeutic Drug MonitoringMarket: Segmentation
Global therapeutic drug monitoring market is segmented on the basis of product type as following: